Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Luo, Guo Feng ^a   Chen, Wei Hai ^a   Liu, Yun ^a   Lei, Qi ^a   Zhuo, Ren Xi ^a   Zhang, Xian Zheng ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; ORGANOPHOSPHORUS COMPOUND; PEPTIDE; SILICON DIOXIDE; TOPOTECAN; TRIPHENYLPHOSPHONIUM METHYLIDE;

CHEMISTRY; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; ENDOCYTOSIS; HUMAN; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; HUMANS; MICROSCOPY, CONFOCAL; NANOPARTICLES; NEOPLASMS; ORGANOPHOSPHORUS COMPOUNDS; PEPTIDES; SILICON DIOXIDE; TOPOTECAN; TUMOR MICROENVIRONMENT;

EID: 84906224507     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06064     Document Type: Article

References (62)

1. Ghosh, P., Han, G., De, M., Kim, C. K. & Rotello, V. M. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 60, 1307-13015 (2008).
2. Xiong, H. M. ZnO nanoparticles applied to bioimaging and drug delivery. Adv. Mater. 25, 5329.-5335 (2013).
3. Jain, T. K. et al. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterial 29, 4012-4021 (2008).
4. Shin, J. et al. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew. Chem. Int. Ed. 48, 321-324 (2009).
5. Quan, C. Y. et al. Core-shell nanosized assemblies mediated by the a-b cyclodextrin dimer with a tumor-triggered targeting property. ACS Nano 4, 4211-4219 (2010).
6. Al-Ahmady, Z. S. et al. Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo. ACS Nano 6, 9335-9346 (2012).
7. Nakamura, T., Akita, H., Yamada, Y., Hatakeyama, H. & Harashima, H. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications. Acc. Chem. Res. 45, 1113-1121 (2012).
8. Zhang, E., Zhang, C., Su, Y., Cheng, T. & Shi, C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov. Today 16, 140-146 (2011).
9. Knop, K., Hoogenboom, R., Fischer, D. & Schubert, U. S. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. 49, 6288-6308 (2010).
10. Otsuka, H.,Nagasaki, Y.&Kataoka, K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 64, 246-255 (2012).
11. Yang, X. Z. et al. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery. ACS Nano 6, 771-781 (2012).
12. Mok, H., Park, J. W. & Park, T. G. Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. Bioconjug. Chem. 19, 797-801 (2008). (Pubitemid 351614534)
13. Yang, X. Z. et al. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery. ACS Nano 6, 771-781 (2012).
14. van der Aa,M. A. E.M. et al. The unclear pore complex: the gateway to successful nonviral gene delivery. Pharm. Res. 23, 447-459 (2006).
15. Mizutani, H., Tada-Oikawa, S., Hiraku, Y., Kojima, M. & Kawanishi, S. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 76, 1439-1451 (2005).
16. Pavillard, V., Kherfellah, D., Richard, S., Robert, J. &Montaudon, D. Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants. Br. J. Cancer 85, 1077-1083 (2001). (Pubitemid 33016012)
17. Wang, H., Wu, Y., Zhao, R. & Nie, G. Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy. Adv. Mater. 25, 1616-1622 (2013).
18. Fan, H. et al. In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL. Biomaterials 33, 1428-1436 (2012).
19. Wang, Y., Gao, S., Ye,W. H., Yoon, H. S. & Yang, Y. Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat. Mater. 5, 791-796 (2006). (Pubitemid 44570860)
20. Meng, H. et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano 7, 994-1005 (2013).
21. Shen, Y. Q. et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J. Am. Chem. Soc. 132, 4259-4265 (2010).
22. Verma, M., Kagan, J., Sidransky, D. & Srivastava, S. Proteomic analysis of cancercell mitochondria. Mat. Rev. Cancer 3,789-795 (2013).
23. He, Q. & Shi, J. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv. Mater. 26, 391-411 (2013).
24. Tarn, D. et al. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Acc. Chem. Res. 46, 792-801 (2014).
25. Lai, J., Shah, B. P., Garfunkel, E. & Lee, K. B. Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release. ACS Nano 7, 2741-2750 (2013).
26. Pan, L., Liu, J., He, Q., Wang, L. & Shi, J. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials 34, 2719-2730 (2013).
27. Xing, L., Zheng, H., Cao, Y. & Che, S. Coordination polymer coated mesoporous silica nanoparticles for pH-responsive drug release. Adv. Mater. 24, 6433-6437 (2012).
28. He, Q., Shi, J., Chen, F., Zhu, M. & Zhang, L. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 31, 3335-3346 (2010).
29. Lu, J., Liong, M., Zink, J. I. & Tamanoi, F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3, 1341-1346 (2007). (Pubitemid 47245524)
30. Zhang, Z. et al. Biocatalytic release of an anticancer drug from nucleic-acidscapped mesoporous SiO2 using DNA or molecular biomarkers as triggering stimuli. ACS Nano 7, 8455-8468 (2013).
31. Dong, J., Xue, M. & Zink, J. I. Functioning of nanovalves on polymer coated mesoporous silica nanoparticles. Nanoscale 5, 10300-10306 (2013).
32. Luo, Z. et al. Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo. ACS Nano 7, 10271-10284 (2013).
33. Kim, H. et al. Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. Adv. Mater. 22, 4280-4283 (2010).
34. Zhao, Y. L. et al. pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles. J. Am. Chem. Soc. 132, 13016-13025 (2010).
35. Angelos, S., Yang, Y. W., Patel, K., Stoddart, J. F. & Zink, J. I. pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes. Angew. Chem. Int. Ed. 47, 2222-2226 (2008).
36. Thomas, C. R. et al. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 132, 10623-10625 (2010).
37. Zhu, C. L. et al. An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates. J. Mater. Chem. 19, 7765-7770 (2009).
38. Radu, D. R. et al. A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J. Am. Chem. Soc. 126, 13216-13217 (2004). (Pubitemid 39382736)
39. Chen, A. M. et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy inmultidrug-resistant cancer cells. Small 5, 2673-2677 (2009).
40. Chen, C. et al. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery. Angew. Chem. Int. Ed. 50, 882-886 (2011).
41. Schlossbauer, A., Kecht, J. & Bein, T. Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. Angew. Chem. Int. Ed. 48, 3092-3095 (2009).
42. Zhu, C. L., Lu, C. H., Song, X. Y., Yang, H. H. & Wang, X. R. Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamerbased molecular gate. J. Am. Chem. Soc. 133, 1278-1281 (2011).
43. Giri, S., Trewyn, B. G., Stellmaker, M. P. & Lin, V. S. Y. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew. Chem. Int. Ed. 44, 5038-5044 (2005). (Pubitemid 41188539)
44. Muhammad, F. et al. pH-triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. J. Am. Chem. Soc. 133, 8778-8781 (2011).
45. Lai, C. Y. et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125, 4451-4459 (2003).
46. Li, Z. Y. et al. One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma. ACS Appl. Mater. Interfaces 5, 7995-8001 (2013).
47. Fugit, K. D. & Anderson, B. D. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan. J. Control Release 174, 88-97 (2014).
48. Marrache, S. & Dhar, S. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc. Natl. Acad. Sci. U.S.A. 109, 16288-16293 (2012).
49. Agemy, L. et al. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc. Natl. Acad. Sci. U.S.A. 108, 17450-17455 (2011).
50. Du, J. Z., Sun, T. M., Song, W. J., Wu, J. & Wang, J. A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. Angew. Chem. Int. Ed. 49, 3621-3626 (2010).
51. Yuan, Y. Y. et al. Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor. Adv. Mater. 24, 5476-5480 (2012).
52. Fields, G. B. & Noble, R. L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35, 161-214 (1990). (Pubitemid 20126875)
53. Leung, C. W. et al. A photostable AIE luminogen for specific mitochondrial imaging and tracking. J. Am. Chem. Soc. 135, 62-65 (2013).
54. Wang, X. H. et al. Poly-L-lysine assisted synthesis of core-shell nanoparticles and conjugation with triphenylphosphonium to target mitochondria. J. Mater. Chem. B 1, 5143-5152 (2013).
55. Fleige, E., Quadir, M. A.&Haag, R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv. Drug Deliv. Rev. 64, 866-884 (2012).
56. Dhar, S. & Lippard, S. J. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. Proc. Natl. Acad. Sci. U.S.A. 106, 22199-22204 (2009).
57. Hong, R. et al. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc. 128, 1078-1079 (2006). (Pubitemid 43190611)
58. Asefa, T. & Tao, Z. Biocompatibility of mesoporous silica nanoparticles. Chem. Res. Toxicol. 25, 2265-2284 (2012).
59. Chen, Y., Chen, H. & Shi, J. In vivo bio-safety evaluations and diagnostic/ therapeutic application of chemically designed mesoporous silica nanoparticles. Adv. Mater. 25, 3314-3376 (2013).
60. Lu, J., Liong, M., Li, Z., Zink, J. I. & Tamanoi, F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6, 1794-1805 (2010).
61. Souris, J. S. et al. Surface charge-meditated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 31, 5564-5574 (2010).
62. Bessalle, R., Kapitkovsky, A., Gorea, A., Shalit, I. & Fridkin, M. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 274, 151-155 (1990). (Pubitemid 20378143)